Clinical trial
Efficacy and Safety of Washed Microbiota Transplantation for Tourette's Syndrome
NCT03764748 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Washed Microbiota Transplantation for Tourette's Syndrome
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 17, 2024
- Completion date
- October 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.